Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.

Mirabelli-Badenier M, Morana G, Pinto F, Uccelli A, Veneselli E, Battaglia FM, Biancheri R, Baglietto MG, Vincent A, Mancardi MM.

Arch Neurol. 2012 Aug;69(8):1064-6. doi: 10.1001/archneurol.2012.234.

PMID:
22507885
2.

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.

Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG.

Ann Neurol. 2010 Apr;67(4):470-8. doi: 10.1002/ana.21917.

PMID:
20437582
3.

Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?

Blanc F, Ruppert E, Kleitz C, Valenti MP, Cretin B, Humbel RL, Honnorat J, Namer IJ, Hirsch E, Manning L, de Seze J.

J Neurol Sci. 2009 Dec 15;287(1-2):69-71. doi: 10.1016/j.jns.2009.09.004. Epub 2009 Sep 27.

PMID:
19786284
4.

Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases.

Mishra N, Rodan LH, Nita DA, Gresa-Arribas N, Kobayashi J, Benseler SM.

J Child Neurol. 2014 May;29(5):677-83. doi: 10.1177/0883073813500527. Epub 2013 Oct 3.

PMID:
24092895
5.

[Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].

Carra-Dalliere C, Thouvenot E, Bonafé A, Ducray F, Touchon J, Charif M.

Rev Neurol (Paris). 2012 Apr;168(4):363-6. doi: 10.1016/j.neurol.2011.07.018. Epub 2012 Mar 7. French.

PMID:
22405456
6.

Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?

Korff CM, Parvex P, Cimasoni L, Wilhelm-Bals A, Hampe CS, Schwitzgebel VM, Michel M, Siegrist CA, Lalive PH, Seeck M.

Arch Neurol. 2011 Aug;68(8):1065-8. doi: 10.1001/archneurol.2011.177. Review.

PMID:
21825244
7.

Acute amnesia and seizures in a young female.

García García ME, Castrillo SM, Morales IG, Di Capua Sacoto D, Dolado AM.

Epileptic Disord. 2013 Dec;15(4):455-60. doi: 10.1684/epd.2013.0607.

PMID:
24165308
8.

Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

Abele M, Weller M, Mescheriakov S, Bürk K, Dichgans J, Klockgether T.

Neurology. 1999 Mar 10;52(4):857-9.

PMID:
10078741
9.

Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.

Planche V, Marques A, Ulla M, Ruivard M, Durif F.

Cerebellum. 2014 Jun;13(3):318-22. doi: 10.1007/s12311-013-0534-3.

PMID:
24218114
10.

Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M.

J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):187-9.

11.

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F.

Brain. 2008 Oct;131(Pt 10):2553-63. doi: 10.1093/brain/awn183. Epub 2008 Aug 7.

12.

Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.

Vianello M, Tavolato B, Armani M, Giometto B.

Cerebellum. 2003;2(1):77-9.

PMID:
12882238
13.

Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.

Georgieva Z, Parton M.

BMJ Case Rep. 2014 Jan 13;2014. pii: bcr2013202314. doi: 10.1136/bcr-2013-202314.

14.

Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.

Bayreuther C, Hieronimus S, Ferrari P, Thomas P, Lebrun C.

Diabetes Metab. 2008 Sep;34(4 Pt 1):386-8. doi: 10.1016/j.diabet.2008.02.002. Epub 2008 Jun 25.

15.

Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.

Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A.

Intern Med. 2001 Sep;40(9):968-71. Review.

16.

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.

Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P.

J Neuroimmunol. 2008 Aug 13;199(1-2):155-9. doi: 10.1016/j.jneuroim.2008.05.015. Epub 2008 Jun 30.

PMID:
18586329
17.

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F.

Arch Neurol. 2001 Feb;58(2):225-30.

PMID:
11176960
18.

Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.

Lopez-Sublet M, Bihan H, Reach G, Dupont S, Didelot A, Mourad JJ, Krivitzky A, Dhote R.

Diabetes Metab. 2012 Jun;38(3):273-5. doi: 10.1016/j.diabet.2012.02.005. Epub 2012 Mar 29.

19.

New autoantibody mediated disorders of the central nervous system.

Lang B, Dale RC, Vincent A.

Curr Opin Neurol. 2003 Jun;16(3):351-7. Review.

PMID:
12858073
20.

Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.

Saidha S, Murphy S, Ronayne A, McCarthy P, Hennessy MJ, Counihan T.

J Neurol. 2010 Jun;257(6):1035-8. doi: 10.1007/s00415-010-5476-9. Epub 2010 Feb 4. No abstract available.

PMID:
20130897
Items per page

Supplemental Content

Write to the Help Desk